نتایج جستجو برای: tumor suppressor protein p53

تعداد نتایج: 1594311  

Journal: :The EMBO journal 2016
Stephen Tutton Greggory A Azzam Nicholas Stong Olga Vladimirova Andreas Wiedmer Jessica A Monteith Kate Beishline Zhuo Wang Zhong Deng Harold Riethman Steven B McMahon Maureen Murphy Paul M Lieberman

Telomeres and tumor suppressor protein TP53 (p53) function in genome protection, but a direct role of p53 at telomeres has not yet been described. Here, we have identified non-canonical p53-binding sites within the human subtelomeres that suppress the accumulation of DNA damage at telomeric repeat DNA. These non-canonical subtelomeric p53-binding sites conferred transcription enhancer-like func...

Journal: :Materials research express 2021

Abstract Determining potential abilities of nanostructures to induce toxicity biological molecules is still a convoluted challenge in the realm nanomedicine. Based on unprecedented achievements two-dimensional nanomaterials nearly all areas applied sciences particularly medicine, we carried out all-atom molecular dynamics simulations assess biologically important, yet unmapped issue biocompatib...

Journal: :Oncology reports 2008
Jana Smardova Diana Grochova Pavel Fabian Mojmir Moulis Jan Smarda Iva Falkova Barbora Ravcukova Jana Vankova Ingrid Vasova

Burkitt's lymphomas (BL) are aggressive rapidly growing tumors typified by a high c-myc expression resulting from t(8;14)(q24;q32), t(2;8)(p12;q24) or t(8;22)(q24;q11) translocations. Alterations of the p53 tumor suppressor are also relatively frequent in BL. Several approaches have been adopted for detection of the p53 aberrations such as immunohistochemical analyses, immunoblotting, DNA seque...

Journal: :iranian journal of medical sciences 0
parisa shahnazari monoclonal antibody research centre, avicenna research institute, acecr, tehran, iran kourosh sayehmiri psychosocial injuries research centre, ilam university of medical sciences, ilam, iran zarrin minuchehr national institute of genetic engineering and biotechnology, nigeb, tehran, iran ardavan parhizkar digestive disease research centre, shariati hospital, tehran university of medical science, tehran, iran hossein poustchi digestive disease research centre, shariati hospital, tehran university of medical science, tehran, iran ghodratollah montazeri digestive disease research centre, shariati hospital, tehran university of medical science, tehran, iran

background: the ability of tumour suppressor protein p53 (p53) to regulate cell cycle processes can be modulated by hepatitis b virus (hbv). while preliminary evidences indicates the involvement of protein-x of hbv (hbx) in altering p53 dna binding, no further data have been accumulated for the significance of serum p53 in chronic hepatitis b virus infected patients. methods: 72 non-cirrhotic a...

Journal: :Journal of virology 2000
M Nevels S Rubenwolf T Spruss H Wolf T Dobner

Previous studies have shown that the adenovirus type 5 (Ad5) E4orf6 gene product displays features of a viral oncoprotein. It initiates focal transformation of primary rat cells in cooperation with Ad5 E1 genes and confers multiple additional transformed properties on E1-expressing cells, including profound morphological alterations and dramatically accelerated tumor growth in nude mice. It has...

2017
Akari Minami Toshiyuki Murai Atsuko Nakanishi Yasuko Kitagishi Mayuko Ichimura Satoru Matsuda

Multiple cell cycle regulatory proteins play an important role in oncogenesis. Cancer cells may arise from dysregulation of various genes involved in the regulation of the cell cycle. In addition, cyclin-dependent kinase inhibitors are regarded as key regulators for cancer cell proliferation. Accordingly, permission of impaired cells by cell cycle checkpoints suppresses carcinogenesis. P53, a m...

Journal: :Cancer research 2015
Shengliang Zhang Lanlan Zhou Bo Hong A Pieter J van den Heuvel Varun V Prabhu Noel A Warfel Christina Leah B Kline David T Dicker Levy Kopelovich Wafik S El-Deiry

The tumor-suppressor p53 prevents cancer development via initiating cell-cycle arrest, cell death, repair, or antiangiogenesis processes. Over 50% of human cancers harbor cancer-causing mutant p53. p53 mutations not only abrogate its tumor-suppressor function, but also endow mutant p53 with a gain of function (GOF), creating a proto-oncogene that contributes to tumorigenesis, tumor progression,...

Journal: :Cancer research 2005
Esther M Hoogervorst Wendy Bruins Edwin Zwart Conny Th M van Oostrom Gerard J van den Aardweg Rudolf B Beems Jolanda van den Berg Tyler Jacks Harry van Steeg Annemieke de Vries

Cellular activity of the tumor suppressor protein p53 is primarily regulated by posttranslational modifications. Phosphorylation of the COOH terminus, including Ser389, is thought to result in a conformational change of the p53 protein, enhancing DNA binding and transcriptional activity. In vitro studies presented here show that, in addition to UV radiation, Ser389 is phosphorylated upon exposu...

Journal: :Cell 2010
Aart G. Jochemsen Yosef Shiloh

The tumor suppressor protein p53, a crucial player in the DNA damage response, is regulated in many ways, most notably through ubiquitination. In this issue, Yuan et al. (2010) identify the deubiquitinating protease USP10 as a new regulator of p53 in the DNA damage response and tumor development.

Journal: :مجله دانشگاه علوم پزشکی کرمانشاه 0
rahim golmohamadi department of anatomical medicine, sabzevar university of medical sciences mehdi nikbakht department of anatomical medicine, isfahan university of medical sciences

introduction: colorectal cancer (crc) is one of the most prevalent cancers in the world. genetic disorders and dietary habits play a part in crc. the most important cancer suppressor gene is p53. different mutations rates in 7th exon of p53 gene are reported in different areas  which may have a relationship with prognosis of crc. this study examines the relationship between mutation in 7th exon...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید